A recent meta-analysis of 2 randomized, controlled field trials conducted in Santiago, Chile, with the licensed live oral typhoid vaccine Ty21a showed that vaccination not only conferred protection against S. Typhi disease, but also against paratyphoid B fever. The overall goal of this application is to study the immunological mechanisms that could mediate this cross-protection. The proposed studies will focus on investigating whether the array of cell-mediated immunity (CMI) and Ab responses elicited by immunization of subjects with the licensed Ty21 a typhoid vaccine, as well as novel attenuated S. Typhi vaccine candidates, which are likely to be involved in protection, cross-react with S. Paratyphi A and B antigens. Specifically, we propose to address the following Specific Aims:
Aim 1. Test the hypothesis that a defined set of CMI responses in circulation play a key role in cross-protection between S. Typhi strain Ty21a and S. Paratyphi B infection in humans. To this end, we will use cells from subjects immunized with Ty21a to evaluate whether there is cross-reactivity between CMI responses (e.g., cytokine production, proliferative responses, cytotoxic activity) to S. Typhi, S. Paratyphi A and S. Paratyphi B. We hypothesize that crossreactivity will be chiefly observed between S. Typhi and S. Paratyphi B, with minor, if any, cross-reactivity with S. Paratyphi A antigens, Aim 2. Evaluate the hypothesis that the CMI responses observed in Ty21a vaccinees that show cross-reactivity between S. Typhi and S. Paratyphi B antigens (Aim 1) are also elicited by oral immunization of subjects with novel attenuated S. Typhi candidate vaccine strains CVD 908-htrA and CVD 909. These studies will assess the likelihood that immunization with these novel attenuated S. Typhi candidate vaccine strains will result in a broad-spectrum S. Typhi and S. Paratyphi B (and perhaps S. Paratyphi A) vaccine against enteric fevers, and Aim 3. Evaluate the hypothesis that immunization of subjects with Ty21a and novel attenuated S. Typhi candidate vaccine strains CVD 908-htrA and CVD 909 elicits the appearance in serum ofAb that cross-react to Salmonella common antigens present in S. Typhi and S. Paratyphi B (e.g., flagella, OmpC, GroEL, O-polysaccharide epitope 12). These studies will include the measurement of circulating antibody secreting cells (ASC), memory B cells (BM) and Ab directed to common Salmonella antigens, as well as IgA-mediated ADCC. The presence of these cross-reactive Ab, ASC and BM cells will suggest that these humoral responses might play an active role in cross-protection.

Public Health Relevance

The vast majority of enteric fevers, a major public health concern, are caused by S. Typhi, S. Paratyphi A and S. Paratyphi B. Additionally, Salmonella spp are category B pathogens that can be used as a bio-terror weapons. Epidemiological evidence that immunization with the Ty21a typhoid vaccine affords cross-protection from S. Paratyphi B infection is already available. The proposed immunological studies directed to unveil cross-reactivity between S. Typhi and S. Paratyphi antigens in humans could significantly advance the development of novel broad-spectrum vaccines against enteric fevers.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland Baltimore
United States
Zip Code
Freedman, John C; Theoret, James R; Wisniewski, Jessica A et al. (2015) Clostridium perfringens type A-E toxin plasmids. Res Microbiol 166:264-79
Li, Jihong; McClane, Bruce A (2014) Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease. Infect Immun 82:4620-30
Moy, Ryan H; Gold, Beth; Molleston, Jerome M et al. (2014) Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals. Immunity 40:51-65
Cuevas, Christian D; Ross, Susan R (2014) Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brain. J Virol 88:7703-14
Boyd, Mary Adetinuke; Tennant, Sharon M; Saague, Venant A et al. (2014) Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines. Clin Vaccine Immunol 21:712-21
Su, Yi-Hsuan; Tsegaye, Mikiyas; Varhue, Walter et al. (2014) Quantitative dielectrophoretic tracking for characterization and separation of persistent subpopulations of Cryptosporidium parvum. Analyst 139:66-73
Xu, Jie; Cherry, Sara (2014) Viruses and antiviral immunity in Drosophila. Dev Comp Immunol 42:67-84
Uzal, Francisco A; Freedman, John C; Shrestha, Archana et al. (2014) Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol 9:361-77
Weir, Dawn L; Laing, Eric D; Smith, Ina L et al. (2014) Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Virol J 11:40
Weir, Dawn L; Annand, Edward J; Reid, Peter A et al. (2014) Recent observations on Australian bat lyssavirus tropism and viral entry. Viruses 6:909-26

Showing the most recent 10 out of 299 publications